Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix.

International journal of oncology

Volumn 17, Issue 2, 2000, Pages 367-373

  Halmos, G ^a   Schally, A V ^a   Kahan, Z ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CETRORELIX; DRUG DERIVATIVE; GONADORELIN; GONADORELIN RECEPTOR; HORMONE ANTAGONIST; TRIPTORELIN;

ADENOCARCINOMA; ANIMAL; ARTICLE; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; OVARY TUMOR;

ADENOCARCINOMA, PAPILLARY; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MICE; MICE, NUDE; MIDDLE AGED; OVARIAN NEOPLASMS; RECEPTORS, LHRH; TRIPTORELIN; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0034242518     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.2.367     Document Type: Article

References (0)